Neelim Healthcare Consulting
Neelim

Clinical Pharmacy Prometric exam questions

Pharmacotherapy, TDM, renal and hepatic dosing, critical care and ID.

Tell us which regulator you are sitting and we send the bank prepared for that authority's exam.

For DHA · DOH · MOHAP · SHA · NHRADHA PHO5482Pass mark DHA 70%From 3 papers · ~150 Qs each
AED 319one-time
About a third of one exam fee
Request this question bank

Tell us your authority and we send the bank for that exam, usually the same day.

Or sit 12 questions free first →

What is riding on this exam

~AED 880
DHA exam fee, per attempt
Paid again on every re-sit. Other regulators' fees are in the table below.
3
UAE attempts - in total
Shared across DHA, DOH, MOHAP and SHA, not three each. Saudi, Qatar, Oman and Kuwait rules are in the FAQ.
70%
DHA pass mark
Pass or fail only. Other authorities set their own pass marks.

One failed attempt costs you the fee again, plus months of delay on your licence, your visa and your start date. This bank costs about a third of one exam fee.

Every regulator: format, pass marks and fees for all GCC licensing exams, each from the regulator's own documents.

The Clinical Pharmacy exam at a glance

DHA (UAE) publishes a Clinical Pharmacy exam of 150 MCQs in 3 hours with a 70% pass mark; DOH (UAE) publishes a Clinical Pharmacy exam of 50-100 MCQs in 1-2 hours, plus a 40-60 minute oral, scored pass or fail. MOHAP, SHA, NHRA do not publish Clinical Pharmacy-specific figures; their regulator-wide format and pass-mark rules are in the full table. SCFHS, QCHP, OMSB, Kuwait MOH publish no exam for this title.

DHA · UAE
Clinical Pharmacy (PHO5482)
150 MCQs in 3 hours · pass mark 70% · USD 240 (about AED 880) · checked September 2026
DOH · UAE
Clinical Pharmacist CBT + Oral
50-100 MCQs in 1-2 hours, plus a 40-60 minute oral · pass mark Pass / fail only · AED 600 · checked October 2026

From each regulator's own exam documents; the DHA row is from the DHA CBT Guideline, Sep 2026. Every other regulator is in the full GCC table.

Try two questions from this bank

Original questions from the bank - pick an answer to see the rationale and reference.

Q1Critical Care, Renal and Hepatic Considerations

Below which eGFR is metformin contraindicated?

Choose an answer to see the rationale.

Q2Cardiovascular Pharmacotherapy

A 55-year-old man without high bleeding risk has had PCI with a drug-eluting stent for NSTEMI. What is the default duration of dual antiplatelet therapy?

Choose an answer to see the rationale.

Not sure where you stand? Sit 12 of these questions free, timed at real exam pace, and see which domains you are weakest in.

Take the free mock exam →

Liked those? The full bank has 450 questions at this standard - every one with a rationale and a reference.

Get the full bank - AED 319

What's inside

  • ✓3 to 6 full-length papers (~150 Q each)
  • ✓No question repeated between papers
  • ✓Four options, one unambiguous best answer
  • ✓A full rationale on every question
  • ✓A real guideline or textbook reference
  • ✓Every sub-topic in the published blueprint
  • ✓Researched by Neelim's exam research team
  • ✓Prepared for your authority's exam, not a generic set

The Clinical Pharmacy exam in every GCC country

Clinical Pharmacy licensing exam in every GCC country
RegulatorExamFormatPass markFee per attempt
Clinical Pharmacy (PHO5482)
150 MCQs in 3 hours70%USD 240 (about AED 880)
DOH
Abu Dhabi, Al Ain and Al Dhafra
Practise →
Clinical Pharmacist CBT + Oral
50-100 MCQs in 1-2 hours, plus a 40-60 minute oralPass / fail onlyAED 600
MOHAP
Northern Emirates - Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah
Practise →
MOHAP licensing exam
Regulator-wide format
Computer-basedNot publishedNot published
SHA
Emirate of Sharjah
Practise →
SHA licensing exam
Regulator-wide format
Set at assessmentNot publishedNot published
SCFHS
Kingdom of Saudi Arabia
Practise →
No exam published for this title
Not in the SCFHS classification exam list; check the title with SCFHS
Not publishedNot publishedNot published
QCHP
State of Qatar
Practise →
No exam published for this title
No DHP Qatar exam blueprint published for this title; check with DHP
Not publishedNot publishedNot published
NHRA
Kingdom of Bahrain
Practise →
NHRA licensing exam
Regulator-wide format
Prometric CBTNot publishedNot published
OMSB
Sultanate of Oman
Practise →
No exam published for this title
No OMSB exam published for this title; check with OMSB
Not publishedNot publishedNot published
Kuwait MOH
State of Kuwait
Practise →
No exam published for this title
Kuwait MOH publishes no exam for this title; check with the MOH
Not publishedNot publishedNot published

Highlighted rows publish figures for this exact Clinical Pharmacy exam; the others show the regulator's general rules.

From each regulator's own exam pages; anything a regulator does not publish says so. Assessment mode also depends on your licence title, so confirm your route on your eligibility notice.

Try 15 free Clinical Pharmacy questions with answersDifferent from the samples on this page - each with a full explanationStart →

What the Clinical Pharmacy exam covers

The published blueprint for this exam breaks into 9 domains and 57 testable sub-topics. Our bank covers every one of them - here is the full map, so you can see exactly what you are expected to know.

Cardiovascular Pharmacotherapy~15%7 topics
  • Heart failure with reduced ejection fraction: guideline-directed therapy
  • Acute coronary syndrome: antiplatelets and secondary prevention
  • Atrial fibrillation: rate, rhythm and stroke prevention
  • Hypertension: drug selection in comorbidities
  • Dyslipidaemia and statin drug interactions
  • Amiodarone and digoxin interactions and toxicity
  • Hypertensive urgency and emergency
Infectious Diseases and Antimicrobial Stewardship~15%8 topics
  • Vancomycin AUC-guided dosing
  • Aminoglycoside extended-interval dosing
  • Beta-lactam allergy assessment and cross-reactivity
  • Resistant gram-negative infections: ESBL and carbapenemase producers
  • Clostridioides difficile infection treatment
  • Urinary tract infection management
  • Community-acquired and hospital-acquired pneumonia
  • Stewardship interventions: de-escalation, IV-to-oral switch, duration
Critical Care, Renal and Hepatic Considerations~12%6 topics
  • Estimating renal function: Cockcroft-Gault and eGFR
  • Drug dosing in CKD, dialysis and CRRT
  • Electrolyte emergencies: hyperkalaemia and hyponatraemia
  • Sedation, analgesia and delirium in the ICU
  • Stress ulcer and VTE prophylaxis in critical illness
  • Dosing in hepatic impairment
Pharmacokinetics and Therapeutic Drug Monitoring~12%6 topics
  • Half-life, steady state and accumulation
  • Loading and maintenance dose calculations
  • Non-linear (Michaelis-Menten) kinetics of phenytoin
  • Protein binding and albumin correction
  • Sampling times for digoxin, aminoglycosides and vancomycin
  • Drug interactions via CYP450 and P-glycoprotein
Endocrine, Respiratory and Gastrointestinal Pharmacotherapy~10%6 topics
  • Diabetes: inpatient insulin and cardiorenal agents
  • Thyroid replacement and drug absorption interactions
  • Asthma: GINA stepwise therapy
  • COPD: GOLD inhaler escalation
  • Helicobacter pylori eradication regimens
  • Inflammatory bowel disease and proton pump inhibitor stewardship
Oncology, Haematology and Anticoagulation~12%7 topics
  • Direct oral anticoagulant dosing and dose reduction criteria
  • Warfarin management and reversal
  • Heparin-induced thrombocytopenia
  • Chemotherapy supportive care: antiemetics, tumour lysis syndrome
  • High-dose methotrexate and leucovorin rescue
  • Febrile neutropenia empirical therapy
  • Safe handling of cytotoxic drugs
Neurology, Psychiatry and Pain~8%6 topics
  • Opioid conversion and equianalgesic dosing
  • Serotonin syndrome and drug combinations
  • Lithium toxicity and interacting drugs
  • Antiepileptic drug interactions and monitoring
  • Antipsychotic adverse effects and monitoring
  • Neuropathic pain pharmacotherapy
Special Populations~8%5 topics
  • Paediatric weight-based dosing
  • Older adults: Beers Criteria and deprescribing
  • Pregnancy and lactation drug safety
  • Obesity dosing weights
  • Renal and hepatic dose adjustment in older adults
Medication Safety, Evidence-Based Practice and Ethics~8%6 topics
  • High-alert medications and look-alike sound-alike drugs
  • Medication error classification and reporting
  • Medication reconciliation at transitions of care
  • Critical appraisal: NNT, relative and absolute risk
  • Pharmacovigilance and adverse drug reaction reporting
  • Professional ethics, confidentiality and conflicts of interest

6 worked Clinical Pharmacy practice questions

Original exam-style questions from the bank, spread across the blueprint domains. They are not real or recalled exam questions. Try each one, then open the answer for the rationale and reference. None of them appear in the free mock exam, so reading them will not spoil it.

  1. Question 1 · Cardiovascular Pharmacotherapy

    An 80-year-old on digoxin 125 micrograms daily for AF rate control is started on amiodarone. What adjustment is recommended?

    1. AReduce the digoxin dose by about half
    2. BIncrease the digoxin dose by half
    3. CNo change is needed
    4. DStop amiodarone after loading
    Show answer and explanation

    Correct answer: A. Reduce the digoxin dose by about half

    Amiodarone inhibits P-glycoprotein and reduces digoxin clearance, roughly doubling digoxin concentrations, so the digoxin dose is reduced by about half with level monitoring. Leaving the dose unchanged risks digoxin toxicity, particularly in an older patient.

    Reference: Amiodarone Prescribing Information; Stockley's Drug Interactions, 12th ed.

  2. Question 2 · Critical Care, Renal and Hepatic Considerations

    A patient on dialysis has potassium 7.1 mmol/L with peaked T waves and widened QRS complexes. What should be given first?

    1. AIV calcium gluconate
    2. BOral sodium polystyrene sulfonate
    3. CIV furosemide
    4. DOral sodium bicarbonate
    Show answer and explanation

    Correct answer: A. IV calcium gluconate

    IV calcium gluconate stabilises the myocardial membrane within minutes and is the first step when hyperkalaemia causes ECG changes. Insulin with glucose then shifts potassium into cells; resins act too slowly for an emergency.

    Reference: UK Kidney Association Clinical Practice Guideline: Treatment of Acute Hyperkalaemia in Adults 2023

  3. Question 3 · Endocrine, Respiratory and Gastrointestinal Pharmacotherapy

    A patient's TSH has risen after she started calcium carbonate and ferrous sulfate taken together with her morning levothyroxine. What is the most appropriate advice?

    1. ATake levothyroxine at least 4 hours apart from calcium and iron
    2. BDouble the levothyroxine dose
    3. CStop the calcium and iron permanently
    4. DTake levothyroxine with breakfast and the minerals
    Show answer and explanation

    Correct answer: A. Take levothyroxine at least 4 hours apart from calcium and iron

    Calcium and iron bind levothyroxine in the gut and reduce its absorption, so separating them by at least 4 hours usually corrects the problem. Increasing the dose without separating the drugs leads to variable control.

    Reference: ATA Guidelines for the Treatment of Hypothyroidism 2014

  4. Question 4 · Infectious Diseases and Antimicrobial Stewardship

    A 58-year-old has bacteraemia from a urinary source with ESBL-producing Klebsiella pneumoniae, susceptible to piperacillin/tazobactam and meropenem. What is the preferred definitive therapy?

    1. APiperacillin/tazobactam
    2. BMeropenem
    3. CCeftriaxone
    4. DAmoxicillin/clavulanate
    Show answer and explanation

    Correct answer: B. Meropenem

    A carbapenem is preferred for ESBL bloodstream infection because the MERINO trial showed higher 30-day mortality with piperacillin/tazobactam even when reported susceptible. Ceftriaxone is hydrolysed by ESBLs and is unreliable.

    Reference: IDSA Guidance on Treatment of Antimicrobial-Resistant Gram-Negative Infections 2024

  5. Question 5 · Neurology, Psychiatry and Pain

    A woman stable on lithium for bipolar disorder develops coarse tremor, vomiting and confusion 2 weeks after a new antihypertensive was added. Her lithium level is 1.9 mmol/L. Which drug most likely caused this?

    1. AAmlodipine
    2. BDoxazosin
    3. CHydrochlorothiazide
    4. DAtenolol
    Show answer and explanation

    Correct answer: C. Hydrochlorothiazide

    Thiazide diuretics reduce renal lithium clearance by increasing proximal sodium and lithium reabsorption, raising lithium levels by around 25-40%. ACE inhibitors and NSAIDs also raise lithium, while amlodipine, doxazosin and atenolol have no clinically important effect on its clearance.

    Reference: Stockley's Drug Interactions, 12th ed.

  6. Question 6 · Oncology, Haematology and Anticoagulation

    An 82-year-old woman with non-valvular AF weighs 58 kg and has a serum creatinine of 95 micromol/L. What apixaban dose is appropriate?

    1. A5 mg twice daily
    2. B2.5 mg once daily
    3. C10 mg twice daily
    4. D2.5 mg twice daily
    Show answer and explanation

    Correct answer: D. 2.5 mg twice daily

    Apixaban is reduced to 2.5 mg twice daily in AF when at least two of age 80 or over, weight 60 kg or less, or creatinine 133 micromol/L or more are present; she meets the age and weight criteria. Once-daily dosing is not a licensed regimen for apixaban.

    Reference: Apixaban Summary of Product Characteristics; EHRA Practical Guide on NOACs 2021

Clinical Pharmacy reference books and guidelines

Every question in this bank names the textbook or guideline its answer rests on. These are the sources our Clinical Pharmacy questions cite most often - the reading list to revise from alongside the bank.

Textbooks

5
  1. 1

    Applied Clinical Pharmacokinetics, Bauer LA

    3rd edition
  2. 2

    Stockley's Drug Interactions

    12th edition
  3. 3

    BC Cancer Drug Manual: Methotrexate

  4. 4

    Evidence-Based Medicine: How to Practice and Teach EBM

    5th edition
  5. 5

    Faculty of Pain Medicine Opioids Aware: Dose Equivalents

Guidelines and standards

10
  1. 1

    IDSA/ESCMID Guideline for Acute Uncomplicated Cystitis and Pyelonephritis in Women

    2010
  2. 2

    Maastricht VI/Florence Consensus Report

    2022
  3. 3

    ASH Guidelines for Management of Venous Thromboembolism: HIT

    2018
  4. 4

    NICE: Hypertension in Pregnancy

    NG133
  5. 5

    IDSA/SHEA Focused Update on C. difficile Infection

    2021
  6. 6

    UK Kidney Association Clinical Practice Guideline: Treatment of Acute Hyperkalaemia in Adults

    2023
  7. 7

    ATA Guidelines for the Treatment of Hypothyroidism

    2014
  8. 8

    IDSA Guidance on Treatment of Antimicrobial-Resistant Gram-Negative Infections

    2024
  9. 9

    AHA/ACC/HFSA Guideline for the Management of Heart Failure

    2022
  10. 10

    GOLD Global Strategy for COPD Report

    2024

Where your regulator publishes a reading list, use the editions it names. Exam questions are not taken from any one book.

Last reviewed September 2026

About these questions: every question is original, researched by Neelim's exam research team, written to the published blueprint, with a rationale and a reference. No recalled or leaked exam content is used. How we write our questions.

Frequently asked questions

Are these real Clinical Pharmacy exam questions?
No. Every item is original, researched by Neelim's exam research team against the exam blueprint published by the health authorities. Real, recalled or leaked exam content breaches the testing bodies' rules and can lead to a permanent exam ban - we do not sell it, and neither should anyone else.
How many questions are in the Clinical Pharmacy bank?
Every bank starts at 3 full-length papers of roughly 150 questions each, the same length as the real computer-based exam, and you can add papers up to 6, including a bonus paper of our hardest questions. The papers do not overlap, so every question is new, and together they cover every sub-topic in the published blueprint.
What is the pass mark for the DHA Clinical Pharmacy exam?
70%. DHA publishes the pass score for each exam, and 70% is the figure for Clinical Pharmacy (PHO5482) in the DHA CBT Guideline, Sep 2026. The result is posted to your Sheryan account as Pass or Fail only - your score is not shared. Elsewhere in the GCC: DOH Pass / fail only.
How many questions are in the DHA Clinical Pharmacy exam, and how long is it?
150 multiple-choice questions in 3 hours, and the time includes registration and the introduction. It is a computer-based test delivered by Prometric at test centres in the UAE and abroad.
How much does the DHA Clinical Pharmacy exam cost?
USD 240 (about AED 880) per attempt, paid again for every re-sit. DHA also charges a flat AED 200 credentialing fee through Sheryan.
How many attempts do I get?
In the UAE, three in total across DHA, DOH, MOHAP and SHA, not three each, under clause 1.5.4 of the Unified PQR (April 2025). Clause 1.5.5 allows one further attempt with a different authority, except on the Consultant route. Elsewhere in the GCC: SCFHS up to 4 a year, QCHP 5 per scope, OMSB no set maximum, Kuwait MOH 3, 6 weeks apart.
Which GCC regulators license the Clinical Pharmacy title?
DHA sets a written exam (Clinical Pharmacy (PHO5482)); DOH sets a written exam (Clinical Pharmacist CBT + Oral). SCFHS, QCHP, OMSB, Kuwait MOH publish no exam for this title. This bank prepares you for the written exams, and its content is the core knowledge any interview or assessment for the title draws on.
How do I receive it?
As PDF files. Card checkout is being set up, so for now you request it from this page and we send it to you directly, usually the same day.

Still unsure whether you even need this exam?

Your route depends on your profession, your licence title and the authority. We have guided over 1,000 professionals through GCC licensing - tell us your situation and we will confirm exactly what you need to sit.